Přejít k hlavnímu obsahu
Header image

Hajduová Katarína

Journals

Paving the way for future PSMA inhibitors: insights from comparative preclinical evaluations of structure modifications. EJNMMI Radiopharmacy and Chemistry. 2025, 10(1), 63, ISSN: 2365-421X, PMID: 41003962,  PDF.
TROMMER, J., M. ULLRICH, F. REISSIG, S. BRUHLMANN, A. NITT-WEBER, Z. NOVÝ, K. HAJDUOVÁ, D. KURFÜRSTOVÁ, R. HENDRYCHOVÁ, J. BOUCHAL, M. PETŘÍK, C. NEUBER, W. SIHVER, S. STADLBAUER, J. PIETZSCH, M. KRELLER, K. KOPKA, C. MAMAT, K. ZARSCHSLER
It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies. EJNMMI Radiopharmacy and Chemistry. 2025, 10(1), 31, ISSN: 2365-421X, PMID: 40536585,
ONDRAK FIALOVA, K., L. ONDRAK, M. VLK, J. KOZEMPEL, K. NOVAKOVA, Z. NOVÝ, K. HAJDUOVÁ, M. HAJDÚCH, M. PETŘÍK, M. PRUSZYNSKI, F. BRUCHERTSEIFER, A. MORGENSTERN
In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac. EJNMMI Radiopharmacy and Chemistry. 2025, 10(1), 16, ISSN: 2365-421X, PMID: 40183827,  PDF.